|
CHA Biotech operates CHA Stem Cell Institute studying both embryonic and tissue-specific
stem cells to maximize the values of stem cells in the future medicine. CHA Biotech has 20
research teams to develop stem cell and gene therapies for various incurable diseases
including neural, diabetes, skeletal, muscular and gynecological diseases |
